COMPOUND PROFILE / PEPTIDES & ANALOGUES
Adipotide (FTPP).
Research draftAdipotide, also called FTPP, is an experimental adipose-targeting peptide construct.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
Adipotide, also called FTPP, is an experimental adipose-targeting peptide construct.
Mechanism
It combines vascular targeting with a pro-apoptotic component intended to affect white-fat blood vessels.
Human research
No convincing therapeutic human evidence was established in this review.
Preclinical & other research
Primate research reported fat and weight changes, with kidney-related toxicity concerns.
Safety & unknowns
Renal toxicity is a central preclinical concern; a human therapeutic margin is not established.
Regulatory status
Preclinical research compound, not an established weight-loss medicine.
Reported use & evidence
The supplied Adipotide (FTPP) profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.